AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

The Authors’ Own Words: Intravenous Use of Intranasal Naloxone: A Case of Overdose Reversal

Feb 7, 2020 by AMERSA

The Authors’ Own Words:  

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Intravenous Use of Intranasal Naloxone: A Case of Overdose Reversal

Smita Das, MD, PhD, MPH; Nina Shah, PharmD; & Murtuza Ghadiali, MD

Substance Abuse Vol. 38, Iss. 1, 2017

“With the rise of opioid overdose deaths, lay-person administration of naloxone, an opiate antagonist to reverse overdose, is expanding as a mode of harm reduction. This case highlights the efficacy of naloxone, the need to counsel patients about overdose risks when entering treatment and the importance of education in naloxone distribution. We hope that the novelty of this case (alternate but luckily efficacious mode of administration) will attract attention to this lifesaving drug so providers as well advocates/policy makers are more informed of naloxone distribution.”

Follow us on twitter to stay up to date with SAj, upcoming publications, and more!

Filed Under: SAj Blog, Uncategorized

Copyright © 2025
Site by: web360